Aviance Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 8.44%
(FY 2023)
- Profit 176.26%
(FY 2023)
- Ebitda 389.34%
(FY 2023)
- Net Worth 0.21%
(FY 2023)
- Total Assets 39.89%
(FY 2023)
About Aviance Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Kuldeep Kothari and Jagdish Kothari serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC153666
- Company No.
153666
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2005
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Aviance Healthcare Private Limited offer?
Aviance Healthcare Private Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Multivitamin Tablets & Capsules, Supradyn Multivitamin Tablet, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Iron Folic Acid Tablet, Ibuprofen Tablets, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Aviance Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuldeep Kothari  | Director | 01-Jun-2005 | Current |
| Jagdish Kothari | Director | 01-Jun-2005 | Current |
Financial Performance of Aviance Healthcare.
Aviance Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.44% increase. The company also saw a substantial improvement in profitability, with a 176.26% increase in profit. The company's net worth moved up by a moderate rise of 0.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aviance Healthcare?
In 2023, Aviance Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aviance Healthcare?
Aviance Healthcare has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aviance Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aviance Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
